Ferring Pharmaceuticals: all 254 studies
Page 2 of 3. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Desmopressin Melt for the Treatment of NocturiaCompletedNCT00477490Phase 3Results posted
- Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation TherapyCompletedNCT00468286Phase 2Results posted
- A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyCompletedNCT00451958Phase 3Results posted
- Exploratory Study Assessing Synchronisation of Egg Sacs With DegarelixCompletedNCT00434122Phase 2Results posted
- Efficacy and Safety of XP12B in Women With MenorrhagiaCompletedNCT00401193Phase 3Results posted
- Efficacy and Safety Study of XP12B in Women With MenorrhagiaCompletedNCT00386308Phase 3Results posted
- A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the KneeCompletedNCT00379236Not applicableResults posted
- Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of LaborCompletedNCT00308711Phase 3Results posted
- The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate CancerCompletedNCT00295750Phase 3Results posted
- Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate CancerCompletedNCT00268892Phase 2/3Results posted
- A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin AlfaCompletedNCT00257556Phase 4Results posted
- Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer PatientsTerminatedNCT00245466Phase 2Results posted
- An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate CancerCompletedNCT00215683Phase 2/3Results posted
- Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsTerminatedNCT00215657Phase 2Results posted
- Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486CompletedNCT00117949Phase 2Results posted
- Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsTerminatedNCT00117312Phase 2Results posted
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerCompletedNCT00117286Phase 2/3Results posted
- A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate CancerCompletedNCT00116779Phase 2Results posted
- A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate CancerCompletedNCT00116753Phase 2Results posted
- Safety Study of XP12B in Women With MenorrhagiaCompletedNCT00113568Phase 3Results posted
- A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod PumpWithdrawnNCT07152730Phase 1
- To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world PracticeActive, not recruitingNCT07029451
- Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World SettingsActive, not recruitingNCT06561958
- REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)CompletedNCT06545877
- Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese PersonsCompletedNCT06515834Phase 1
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.TerminatedNCT06511791Phase 1
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian StimulationTerminatedNCT06466486Phase 1
- A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.WithdrawnNCT06390111Phase 4
- A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy PersonsCompletedNCT06298032Phase 1
- A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisWithdrawnNCT06260267Phase 1
- ADSTILADRIN Early Utilization and Outcomes in the Real World SettingTerminatedNCT06026332
- A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy SubjectsCompletedNCT05924321Phase 1
- REBYOTA™ Prospective RegistryCompletedNCT05835219
- Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)Active, not recruitingNCT05704244Phase 3
- Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian StimulationWithdrawnNCT05571111Phase 2
- Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical PracticeCompletedNCT05499052
- A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy WomenCompletedNCT04902131Phase 1
- MEDAM (Menopur Retrospective Data prograM)CompletedNCT04876300
- Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility TreatmentWithdrawnNCT04814940
- Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian WomenCompletedNCT04773353Phase 3
- General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)CompletedNCT04773314
- NOCDURNA PASS Study Using Registries in Denmark, Germany and SwedenCompletedNCT04740645
- Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)CompletedNCT04654039
- Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical PracticeCompletedNCT04503707
- Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in KoreaCompletedNCT04499495
- Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)CompletedNCT04340895Not applicable
- Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)CompletedNCT04329975
- A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the USCompletedNCT04125186
- Cortiment® MMX Pharmacokinetic StudyCompletedNCT04080713Phase 1
- Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®TerminatedNCT03697031
- Drug Use-Results Survey on Picoprep® Combination PowderCompletedNCT03631446
- A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.CompletedNCT03564509Phase 2
- To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative ColitisCompletedNCT03412682Phase 3
- Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection ProceduresCompletedNCT03393780
- Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner SyndromeTerminatedNCT03274973
- Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With DegarelixCompletedNCT03193645
- Study of Minirin Melt® in Adult Patients With NocturiaTerminatedNCT03089073
- A Randomised Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at TermCompletedNCT03067727Phase 3
- An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at TermCompletedNCT03067597Phase 3
- Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese SubjectsCompletedNCT03051009Phase 3
- A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®CompletedNCT02935335
- Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female SubjectsCompletedNCT02905682Phase 3
- Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male SubjectsCompletedNCT02904759Phase 3
- Safety and Efficacy of Firmagon® (Degarelix) for InjectionCompletedNCT02886598
- A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With InfertilityCompletedNCT02835469
- A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate CancerCompletedNCT02726009Phase 4
- Effectiveness of Cortiment® in Patients With Ulcerative ColitisCompletedNCT02586259
- A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate CancerCompletedNCT02526784Phase 3
- Pharmacokinetics of Degarelix in Chinese Patients With Prostate CancerCompletedNCT02468284Phase 1
- Elobixibat Colonic Motor Function StudyWithdrawnNCT02392546Phase 2
- A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for ColonoscopyCompletedNCT02386449Phase 4
- QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)CompletedNCT02368743
- Documentation of the Efficacy of Desmopressin Within the Context of Surgical ProceduresCompletedNCT02368730
- An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension PhaseCompletedNCT02368717Phase 3
- A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) TreatmentCompletedNCT02309671Phase 2
- Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis TreatmentCompletedNCT02261636
- REgistry of MisOprostol 200 µg Vaginal dElivery SystemCompletedNCT02242214
- Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.CompletedNCT02234089
- Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate CancerCompletedNCT02229253
- Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's DiseaseCompletedNCT02193048
- A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone DeficiencyCompletedNCT02173821Phase 3
- Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X DeviceTerminatedNCT02018172
- An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human EmbryosCompletedNCT02018159
- An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate CancerCompletedNCT02015871Phase 3
- Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese FemalesCompletedNCT01923194Phase 3
- Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) ProgramCompletedNCT01922193Phase 3
- Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in ArgentinaCompletedNCT01861236
- Daytime Impact Sleep StudyTerminatedNCT01779466Phase 2
- Monitoring of Safety and Tolerance of PICOPREP in Clinical PracticeTerminatedNCT01748591
- One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese PopulationCompletedNCT01744366Phase 3
- Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®WithdrawnNCT01731028
- Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy InitiationCompletedNCT01729676
- Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine ContractionsCompletedNCT01723982Phase 2
- Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.CompletedNCT01703728
- Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult MenCompletedNCT01694498Phase 2
- Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult WomenCompletedNCT01684800Phase 2
- Study of the Cleavage of the Egg in Relation to the Stimulation TreatmentCompletedNCT01674894
- A Study of Minirin Melt in 24 Months Treatment in Patients With NocturiaCompletedNCT01552395
- Mesalazine (PENTASA®) in Ulcerative ColitisCompletedNCT01517607
- Tolerability of Pentasa Sachet in Patients With Ulcerative ColitisCompletedNCT01517594